Skip to Main Content

Author Details

Subbaiah Chary Nimmagadda
University Hospital Luebeck
2012
18
8
PMIDPaper TitleJournal TitlePublished Year
37423893Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells.Br J Haematol2023
37756525Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.Blood2023
34792186Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.Br J Haematol2022
35804097GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia.Leukemia2022
35795041Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.Front Oncol2022
35661690Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects.Signal Transduct Target Ther2022
36457063Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia.J Hematol Oncol2022
35158754High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in <i>MLL/AF9</i> Acute Myeloid Leukemia.Cancers (Basel)2022
34760702Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis.Front Oncol2021
35008835Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS).Int J Mol Sci2021
30651113Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K<sub>v</sub>1.3 potassium channels, AKT and ERK1/2 signaling.Cell Commun Signal2019
30828789Targeting RIPK1 in AML cells carrying FLT3-ITD.Int J Cancer2019
30765477SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.Haematologica2019
29109446Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.Leukemia2018
30024857JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.J Clin Invest2018
28233092Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.J Cancer Res Clin Oncol2017
23503467A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis.Oncogene2014
22791710Protein kinase D1 mediates anchorage-dependent and -independent growth of tumor cells via the zinc finger transcription factor Snail1.J Biol Chem2012
  • 1 - 18 of 18

Recommended Authors

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Anna Senina
Huntsman Cancer Institute, The University of Utah
Career Start Year 2013
Number of shared co-authors 2
Helong Zhao
Versiti Blood Research Institute and Medical College of Wisconsin
Career Start Year 2012
Number of shared co-authors 2
Taher Abbasi
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 2
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Career Start Year 2008
Number of shared co-authors 0
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 2
Theodore P Braun
Oregon Health & Science University
Career Start Year 2005
Number of shared co-authors 2
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 2
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 2
Giovanni Roti
University of Parma
Career Start Year 2003
Number of shared co-authors 0
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 2
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 2
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
Arnaud Jacquel
Universite Cote d'Azur, INSERM U5
Career Start Year 1995
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 1
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 2
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 1
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 0
Patrick Auberger
Universite Cote d'Azur, INSERM U5
Career Start Year 1982
Number of shared co-authors 0
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 3
Donald L Durden
Atrium Health-Levine Cancer Institute
Career Start Year 1979
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Cyrus Khandanpour
University Hospital of Muenster
Co-authored papers 9
Daria Frank
University Hospital Muenster
Co-authored papers 7
Pradeep Kumar Patnana
University Munster
Co-authored papers 7
Bertram Opalka
University Hospital Essen.
Co-authored papers 5
Julian Varghese
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 4
Hiroko Tanaka
Tokyo Medical and Dental University
Co-authored papers 4
Xiaoqing Xie
University Hospital Munster
Co-authored papers 4
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 3
Frank Rosenbauer
University Munster
Co-authored papers 3
Yahya Al-Matary
University Hospital Essen.
Co-authored papers 3
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Co-authored papers 2
Wolfgang E Berdel
University Hospital Munster
Co-authored papers 2
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 1
Ashok Kumar Jayavelu
German Cancer Research Center (DKFZ)
Co-authored papers 1
Stefan Hutter
University Hospital
Co-authored papers 1
Doris Steinemann
Hannover Medical School
Co-authored papers 1
J??rgen Klingauf
University of Munster
Co-authored papers 1
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 1
Lianghao Mao
German Cancer Research Center (DKFZ)
Co-authored papers 1
Hauke Busch
Co-authored papers 1
Gudrun G??hring
Hannover Medical School
Co-authored papers 1
Georg Lenz
University Hospital of Muenster
Co-authored papers 1
Jana H??ve
University of Munster
Co-authored papers 1
Matthias Mann
Max-Planck-Institute of Biochemistry Munich
Co-authored papers 1
Anja Fischer
Technical University of Munich
Co-authored papers 1
Virginie Calderon
Institut de recherches cliniques de Montreal
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Gregor Hoermann
Co-authored papers 1
Niels Weinhold
Co-authored papers 1
Longlong Liu
Guangzhou Medical University
Co-authored papers 1
Release 1.2